Prognostic value of the cyclin-dependent kinase inhibitor p27Kip1 in gastric cancer

被引:0
|
作者
Müller, W
Grabsch, H
Takeno, S
Noguchi, T
Hommel, G
Gabbert, HE
机构
[1] Univ Dusseldorf, Inst Pathol, D-40225 Dusseldorf, Germany
[2] Univ Mainz, Inst Med Stat, D-6500 Mainz, Germany
关键词
p27; gastric cancer; prognosis; cell cycle;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In the present study, the expression and prognostic role of p27 were immunohistochemically investigated in 413 curatively resected gastric carcinomas. Strong p27 expression in more than 50% of the armour cells could be detected in 57.4% (n=237) whereas 42.6% of the tumours (n=176) only showed p27 expression in less than 50% of the tumour cells. No significant col-relation could be observed between p27 expression and the prognostic parameters pT category, pN category, blood and lymphatic vessel invasion as well as with tumour histology. Concerning other cell cycle associated proteins, p27 expression was inversely correlated with p21 expression, however; there was no correlation either with cyclin DI and cyclin E or with expression of p53, bcl-2 and tumour cell proliferation. Univariate survival analysis revealed a poorer prognostic outcome for patients with armours expressing p27 in more than 50% of the tumour cells (p<0.049). However; by multivariate analysis, this prognostic influence of p27 could not be verified as independent from the known prognostic parameters of the pTNM-system (p<0.325). The present data on 413 curatively resected gastric carcinomas suggest, that expression of p27, analyzed alone or in combination with multiple cell cycle regulatory proteins, has no prognostic value in gastric cancer.
引用
收藏
页码:1787 / 1792
页数:6
相关论文
共 50 条
  • [1] Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27Kip1
    Hiromura, K
    Pippin, JW
    Fero, ML
    Roberts, JM
    Shankland, SJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (05): : 597 - 604
  • [2] P27kip1:: A multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers
    Lloyd, RV
    Erickson, LA
    Jin, L
    Kulig, E
    Qian, X
    Cheville, JC
    Scheithauer, BW
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (02): : 313 - 323
  • [3] Prognostic impact of cyclin-dependent kinase inhibitor p27kip1 node-positive breast cancer
    Tsuchiya, A
    Zhang, GJ
    Kanno, M
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 1999, 70 (04) : 230 - 234
  • [4] Expression of cyclin-dependent kinase inhibitor p27kip1 in malignant lymphomas
    Oh, YH
    Park, CK
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2000, 15 (04) : 399 - 406
  • [5] Modulation of astrocyte proliferation by cyclin-dependent kinase inhibitor p27Kip1
    Koguchi, K
    Nakatsuji, Y
    Nakayama, K
    Sakoda, S
    [J]. GLIA, 2002, 37 (02) : 93 - 104
  • [6] Analysis of the cyclin-dependent kinase inhibitor p27Kip1 in muscle invasive bladder cancer
    Serth, J
    Kuczyk, M
    Machtens, S
    Bokemeyer, C
    Herrmann, R
    Hartmann, J
    Knüchel, R
    Jonas, U
    [J]. ONCOLOGY REPORTS, 1999, 6 (01) : 229 - 233
  • [7] BRCA1 transactivates the cyclin-dependent kinase inhibitor p27Kip1
    Elizabeth A Williamson
    Farnaz Dadmanesh
    H Phillip Koeffler
    [J]. Oncogene, 2002, 21 : 3199 - 3206
  • [8] BRCA1 transactivates the cyclin-dependent kinase inhibitor p27Kip1
    Williamson, EA
    Dadmanesh, F
    Koeffler, HP
    [J]. ONCOGENE, 2002, 21 (20) : 3199 - 3206
  • [9] Clinical significance of cyclin-dependent kinase inhibitor p27Kip1 expression and proliferation in non-Hodgkin's lymphoma:: independent prognostic value of p27Kip1
    Moller, MB
    Skjodt, K
    Mortensen, LS
    Pedersen, NT
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 (03) : 730 - 736
  • [10] The cyclin-dependent kinase inhibitor p27Kip1 safeguards against inflammatory injury
    Vuddhidej Ophascharoensuk
    Matthew L. Fero
    Jeremy Hughes
    James M. Roberts
    Stuart J. Shankland
    [J]. Nature Medicine, 1998, 4 : 575 - 580